Dr Clotilde LévecqueClotilde

Research

I first joined the Monaco group to work on the functional characterization of the VPS13 protein family (VPS13A/Chorein, VPS13B, C and D). Recently, some mutations in the VPS13A and in VPS13B (or COH1) genes have been identified in Chorea-acanthocytosis (ChAc) patients and Cohen syndrome respectively. The genes encoding these proteins have been characterized but, to date, we have no information on the function of these human proteins.

In June 2006, I got involved in the dyslexia project. We have previously described a risk haplotype associated with dyslexia and shown that this haplotype is associated with a reduction of KIAA0319 gene expression. Interference with rat Kiaa0319 expression in utero disrupts neuronal migration in the developing cerebral cortex. However, the precise function of this protein and its involvement in neuronal migration are still unclear. In order to gain more information on KIAA0319 function, I performed several yeast two hybrid screens, using different fragments of KIAA0319 as baits, which led to the identification of several potential binding partners. Further analysis on the first candidate identified, AP-2, have shown that, after KIAA0319 reaches the plasma membrane, it is internalized back into the cell via a clathrin mediated pathway. I am actually following up the results of the yeast two hybrid screens, to confirm the interaction detected using others methods and to characterized the biological effects of these interactions.

I am a STEM Ambassador (www.stemnet.org.uk/content/ambassadors) and occasionally help out with public engagement activities such as workshops here at the Wellcome Trust Centre for Human Genetics or in schools or for events such as Science in the kitchen/Oxfordshire Science festival.

Publications

BOOK CHAPTER